Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Nausea; dull headache behind both eyes and top of head; warm and dull headache behind both eyes and top of head; Day 1 and 2 post booster: 101 Fever; fatigue; chills; sore arm; aches; sweating down front of torso; Dose received: 3; This is a spontaneous report from a contactable reporter (consumer or other non hcp). The reporter is the patient.   A 47-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm , administration date 06Jan2022 at 14:30 (Lot number: 33130BA) at the age of 47 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing) and "Sulfonamide allergy" (unspecified if ongoing), notes: Known allergy: Sulfa. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, Lot number: EN6203, Anatomical location: Arm Left, Administration Time: 14:30, Route of administration: Unspecified), administration date: 12Mar2021, when the patient was 46 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 1, SINGLE Lot number: EL9267, Administration Time: 14:30, Route of administration: Unspecified), administration date: 19Feb2021, when the patient was 46 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 06Jan2022 at 14:30, outcome "unknown", described as "Dose received: 3"; PYREXIA (non-serious) with onset 07Jan2022, outcome "recovered" (09Jan2022), described as "Day 1 and 2 post booster: 101 Fever"; FATIGUE (non-serious) with onset 07Jan2022, outcome "recovering", described as "fatigue"; CHILLS (non-serious) with onset 07Jan2022, outcome "recovering", described as "chills"; PAIN IN EXTREMITY (non-serious) with onset 07Jan2022, outcome "recovering", described as "sore arm"; PAIN (non-serious) with onset 07Jan2022, outcome "recovering", described as "aches"; HYPERHIDROSIS (non-serious) with onset 07Jan2022, outcome "recovering", described as "sweating down front of torso"; NAUSEA (non-serious) with onset 10Jan2022, outcome "recovering", described as "Nausea"; HEADACHE (non-serious) with onset 10Jan2022, outcome "recovering", described as "dull headache behind both eyes and top of head"; FEELING HOT (non-serious) with onset 10Jan2022, outcome "recovering", described as "warm and dull headache behind both eyes and top of head". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, fatigue, chills, pain in extremity, pain, hyperhidrosis, nausea, headache and feeling hot.  Additional information: The patient did not receive other vaccines within four weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient reported the events as she was very concerned of timing of boosters and dosage. Her body cannot handle these two shots 10 months apart and she was concerned for any child, adult, senior, herself in future. The patient received round the clock Tylenol and cold, wash cloths as treatment for the reported events.